Skip to main content

Elevated BMI Linked to Postacute Sequelae of SARS-CoV-2 in Children

Medically reviewed by Carmen Pope, BPharm. Last updated on Oct 30, 2024.

By Elana Gotkine HealthDay Reporter

WEDNESDAY, Oct. 30, 2024 -- For children with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, elevated body mass index (BMI) is associated with an increased risk of postacute sequelae of SARS-CoV-2 infection (PASC), according to a study published online Oct. 28 in JAMA Network Open.

Ting Zhou, M.D., Ph.D., from the University of Pennsylvania in Philadelphia, and colleagues conducted a retrospective cohort study in 26 U.S. children's hospitals to quantify the association of BMI status before SARS-CoV-2 infection with pediatric PASC risk. Data were included for 172,136 participants (mean age at cohort entry, 13.1 years).

The researchers found that participants with obesity and severe obesity had a significantly increased risk for PASC compared with those with healthy weight (relative risks, 1.25 and 1.42, respectively) when identified using the diagnostic code. There was an increased risk for any occurrences of PASC symptoms and conditions among those with obesity and severe obesity compared with those with healthy weight (relative risks, 1.11 and 1.17, respectively); when assessing total incident occurrences among those with overweight, obesity, and severe obesity, the association held (relative risks, 1.05, 1.13, and 1.18, respectively).

"Addressing obesity as a modifiable risk factor could alleviate the burden of PASC and improve pediatric health postpandemic," the authors write. "Further research is needed to explore specific PASC symptoms associated with BMI."

Several authors disclosed ties to the pharmaceutical industry.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Posted October 2024

Further Support and Information on COVID-19

Read this next

Metformin Beneficial for Osteoarthritis Knee Pain in Overweight, Obesity

THURSDAY, May 1, 2025 -- For patients with overweight or obesity and symptomatic knee osteoarthritis, metformin is associated with a greater improvement in knee pain than placebo...

Many Medicaid Enrollees Have Restricted Access to SGLT2 Inhibitors, GLP-1 Receptor Agonists

WEDNESDAY, April 30, 2025 -- Many Medicaid enrollees with type 2 diabetes have restricted access to cardioprotective medications, including sodium-glucose cotransporter-2...

Prevalence of Most Cancer Risk Factors Unchanged Before, After Pandemic

THURSDAY, April 24, 2025 -- Smoking rates continued to decline during the COVID-19 pandemic, but other major risk factors for cancer remained stable, according to a study...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.